Fulvestrant for hormone-sensitive metastatic breast cancer Read Authors' Conclusions
Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer Read Authors' Conclusions
Nipple- and areola-sparing mastectomy for the treatment of breast cancer Read Authors' Conclusions
Topic: Breast cancer in women
Acupoint stimulation might reduce fatigue and pain minimally in women with breast cancer (Complement Ther Med 2016 Aug)
Suboptimal health-related quality of life after diagnosis reported in young, black female breast cancer survivors (Breast Cancer Res Treat 2016 Nov)
Topic: Chemotherapy for early and locally advanced breast cancer
Dose-dense adjuvant chemotherapy may not increase 5-year survival compared to standard chemotherapy in women with nonmetastatic node-positive or high-risk node-negative breast cancer (JAMA 2016 Nov 8)
Fulvestrant 500 mg increases progression-free survival compared to anastrozole 1 mg in postmenopausal women with estrogen receptor- and/or progesterone receptor-positive nonvisceral locally advanced or metastatic breast cancer (Lancet 2016 Dec 17)
ASCO clinical practice guideline on ovarian suppression as adjuvant endocrine therapy for women with hormone receptor-positive breast cancer (National Guideline Clearinghouse 2016 Oct 31)
To access full text you may have to log in to your NHS Athens account (click here to register for free). If full text is not available then please email us to request a copy.
